I think it is important to keep the options granted to the board and the PP separate in our discussions. The options granted to the board is done by each and every junior company in the market. This is a non issue. The issue is the price of the PP and the timing of this PP. Only time will tell. For example come Feb. if our price is north of $1, $2, or $3 than any criticism of the PP will be warranted unless we were to see this $20 million used in a capacity we don't know about today. Of course that unknown capacity would have to be good for us.